Key result
ITEC-CHF telemonitoring achieves ~91% usability among heart failure patients after six months.
Why the study?
Little is known about the usability and patients' willingness to engage with telemonitoring technology for chronic heart failure management.
Does the ITEC-CHF telemonitoring program demonstrate good usability and patient acceptance in patients with chronic heart failure?
Cross-Sectional (n=67)
Does the ITEC-CHF telemonitoring program demonstrate good usability and patient acceptance in patients with chronic heart failure?
The ITEC-CHF telemonitoring program demonstrated high usability and patient acceptance for self-management in patients with chronic heart failure.
High usability and acceptance of CHF telemonitoring supports routine integration into self-management; leaves open effects on clinical outcomes.
BACKGROUND: Telemonitoring enables care providers to remotely support outpatients in self-managing chronic heart failure (CHF), but little is known about the usability and patients' willingness to engage with this technology. OBJECTIVE: This study aims to evaluate feedback from patients with CHF following participation in the Innovative Telemonitoring Enhanced Care program for CHF (ITEC-CHF) study. METHODS: The telemonitoring intervention consisted of three components: remote weight monitoring, structured telephone support, and nurse-led collaborative care. Participants were provided with electronic weighing scales (W550; ForaCare), and a computer tablet (Galaxy Tab A; Samsung). They were asked to weigh themselves on the provided scales daily. Telemonitoring was integrated with a personal assistance call service and a nurse care service according to their workflows in usual care. Feedback on the usability of ITEC-CHF was collected via survey from study participants following 6 months of receiving telemonitoring care for their body weight. Survey responses were provided on a 5-point Likert scale and through open-ended questions to determine participants' perceived benefits and barriers to using ITEC-CHF. RESULTS: A total of 67 participants (49/67, 73% male), with a mean age of 69.8 (SD 12.4) years completed the survey. The majority of participants agreed or strongly agreed that the ITEC-CHF program was easy to use (61/67, 91%), easy to navigate (51/65, 78%), useful (59/65, 91%), and made them feel more confident in managing their weight (57/67, 85%). Themes related to participants' perceptions of telemonitoring included increased support for early intervention of clinical deterioration, improved compliance to daily weighing, a sense of reassurance, and improved self-care and accountability, among others. CONCLUSIONS: ITEC-CHF was rated highly on usability and was well accepted by users as part of their routine self-management activities. Participants were willing to use telemonitoring because they perceived a broad spectrum of benefits for CHF management. TRIAL REGISTRATION: Australian New Zealand Clinical Trial Registry ID ACTRN 12614000916640; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=366691.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2021) conducted a cross-sectional in Chronic heart failure (n=67). Innovative Telemonitoring Enhanced Care program for CHF (ITEC-CHF) was evaluated on Usability (program was easy to use). The ITEC-CHF telemonitoring program was rated as easy to use by 91% of participants and made 85% feel more confident in managing their weight after 6 months of use.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: